Independent Clinical Trial Site Grows Through Excellence In Trial Compliance LOUISVILLE, KY, UNITED STATES, January 30, ...

When I opened my laptop this morning, up popped a message on LinkedIn: Congratulations on 21 years at Allergan!Stopped me in my tracks, to be honest. That is as long as my practice, SkyVision Centers, ...

The Sodium Fluorescein Eye Drops Market encompasses specialized ophthalmic solutions used primarily for diagnostic procedures in eye care. These drops contain fluorescein dye, which highlights corneal ...

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

The offering is expected to close on February 18, 2026, subject to the satisfaction of customary closing conditions. Sidley Austin LLP served as counsel to Opus Genetics in connection with the ...

Stephenson, MD, FACS, shares insights on evolving LAL technology and best practices for managing the ocular surface before ...

Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S. Dr.

With harsh winds outdoors and dry heat indoors, winter conditions create the perfect recipe for uncomfortable, itchy dry eyes. Eye drops can help—especially if your doctor prescribes a targeted ...

The dosage of Xdemvy (lotilaner ophthalmic solution) for Demodex blepharitis is typically 1 drop per eye twice daily for 6 weeks. It’s important to take the Xdemvy dosage your doctor prescribes.

The price of Xdemvy can vary depending on your insurance plan, the pharmacy you choose, and your specific treatment plan. Xdemvy is a brand-name drug, and there’s currently no generic version ...

The price you pay for Xdemvy may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...

In patients with open-angle glaucoma or ocular hypertension, 3-month treatment with a preservative-free ophthalmic gel of bimatoprost 0.01% was noninferior to the commercially available preserved ...